USMLE Step 1 & 2 Bone Disorders (osteoporosis, Paget's)
Last updated: May 2, 2026
Bone Disorders (osteoporosis, Paget's) questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
Osteoporosis is a quantitative defect — normal bone mineralization but reduced bone mass — diagnosed by DEXA T-score ≤ -2.5 with normal calcium, phosphate, and alkaline phosphatase. Paget's disease is a focal disorder of disordered, accelerated bone remodeling producing thickened but mechanically weak bone, classically with isolated alkaline phosphatase elevation and normal calcium/phosphate. Both feature normal serum calcium, but Paget's gives you a dramatically elevated alk phos and characteristic imaging (cortical thickening, lytic-then-sclerotic phases), while osteoporosis labs are essentially clean and the diagnosis is densitometric.
Elements breakdown
Postmenopausal/Senile Osteoporosis
Decreased bone mass from estrogen loss or age-related remodeling imbalance, with normal mineralization
- DEXA T-score ≤ -2.5 at hip or spine
- Normal calcium, phosphate, alk phos, PTH
- Vertebral compression fracture or fragility fracture from low trauma
- Risk factors: postmenopausal, low BMI, smoking, glucocorticoids
- First-line therapy: bisphosphonate (alendronate, zoledronic acid)
Secondary Osteoporosis
Bone loss driven by an identifiable medical condition or drug, not just age/menopause
- Glucocorticoid use > 3 months at ≥ 5 mg/day prednisone
- Hyperthyroidism, hyperparathyroidism, hypogonadism
- Multiple myeloma, malabsorption, chronic kidney disease
- Workup: TSH, PTH, 25-OH vitamin D, SPEP, testosterone (men)
- Treat underlying cause AND give bisphosphonate
Common examples:
- Long-term prednisone for asthma
- Anorexia nervosa with amenorrhea
- Hypogonadism after orchiectomy
Osteomalacia (key mimic — different disease)
Defective mineralization of osteoid from vitamin D deficiency or phosphate wasting
- Low calcium, low phosphate, high alk phos
- High PTH (secondary hyperparathyroidism)
- Bone pain and proximal muscle weakness
- Looser zones (pseudofractures) on imaging
- Treat with vitamin D and calcium
Paget's Disease of Bone
Focal disorder of disordered osteoclastic resorption followed by chaotic osteoblastic formation, producing mosaic-pattern woven bone
- Isolated elevated alkaline phosphatase
- Normal calcium and phosphate
- Cortical thickening, blade-of-grass lytic front, mixed lytic-sclerotic on x-ray
- Bone scan: intense focal uptake
- Skull, pelvis, femur, tibia, vertebrae most common
- Treatment: bisphosphonate (zoledronic acid preferred)
Common examples:
- Increasing hat size
- Unilateral hearing loss from temporal bone involvement
- Bowing of tibia
Paget's Complications
What a stable Paget's patient develops that prompts the case
- Cranial nerve compression (CN VIII deafness, CN II vision loss)
- High-output cardiac failure from AV shunting in vascular bone
- Pathologic fracture through weakened woven bone
- Osteosarcoma in long-standing disease (rare but exam-favorite)
- Spinal stenosis from vertebral expansion
Common patterns and traps
The Clean-Labs Fragility Fracture
A postmenopausal or elderly patient sustains a fracture from low-energy trauma (fall from standing, lifting a grocery bag, a cough that breaks a rib). Calcium, phosphate, alk phos, PTH, and 25-OH vitamin D are all normal. The exam wants you to recognize that normal labs do not exclude bone disease — the diagnostic test is DEXA, and the answer is bisphosphonate even before you order the scan if a fragility fracture has already occurred at the hip or spine.
An answer like "Begin alendronate" or "Order DEXA scan" rather than "Reassure and recheck calcium in 6 months."
The Isolated Alk Phos Pattern
An older patient (typically > 55) is found incidentally on routine labs to have an alkaline phosphatase 3-10x normal, with normal calcium, phosphate, GGT, and liver enzymes. The normal GGT is the tell that this is bone-derived, not hepatic, alk phos. Imaging of a symptomatic site (skull, pelvis, long bone) shows cortical thickening, lytic fronts, or mixed lytic-sclerotic lesions.
An answer like "Plain radiographs of the skull and pelvis" or "Zoledronic acid" rather than "Liver ultrasound" or "Hepatology referral."
The High-Output Failure Trap
A patient with known Paget's develops dyspnea, edema, and a hyperdynamic precordium. The trap is to call this congestive heart failure from coronary disease and start standard HF therapy. The Pagetic bone is hypervascular — extensive disease creates AV shunts that drive a high-output state. Treatment is to suppress bone turnover with a bisphosphonate, not to escalate diuresis indefinitely.
An answer like "Zoledronic acid infusion" rather than "Increase furosemide" or "Cardiac catheterization."
The Glucocorticoid Bone-Loss Setup
A patient on chronic prednisone (asthma, polymyalgia rheumatica, transplant, IBD) presents with a vertebral compression fracture or back pain after minor exertion. Glucocorticoids cause rapid bone loss within the first 3-6 months, even at modest doses, and prophylaxis is indicated for anyone expected to take ≥ 5 mg prednisone daily for ≥ 3 months. The exam wants you to start a bisphosphonate alongside calcium and vitamin D, not just supplement.
An answer like "Start oral alendronate, calcium, and vitamin D" rather than "Calcium and vitamin D alone" or "Stop prednisone immediately."
The Osteomalacia Distractor
A vignette gives you bone pain, proximal muscle weakness, and a fragility-pattern fracture, tempting you toward osteoporosis. But the labs show low calcium, low phosphate, elevated alk phos, and elevated PTH — that's secondary hyperparathyroidism from vitamin D deficiency, and the diagnosis is osteomalacia, not osteoporosis. Treatment is vitamin D and calcium replacement, not a bisphosphonate.
An answer like "Ergocalciferol and calcium supplementation" rather than "Alendronate" when the calcium and phosphate are low.
How it works
Imagine Mrs. Donnelly, 72, who comes in after a wrist fracture from a low fall. Her labs — calcium 9.4, phosphate 3.5, alk phos 88, PTH 38 — are all normal, and DEXA shows a femoral neck T-score of -2.8. That clean lab panel plus the densitometric finding plus a fragility fracture nails postmenopausal osteoporosis, and you reach for alendronate. Now imagine a different 72-year-old, Mr. Vasquez, who tells you his hat no longer fits and he's developed left-sided hearing loss; his alk phos is 612 with calcium 9.6 and phosphate 3.4, and a skull film shows cotton-wool patches with cortical thickening. The isolated alk phos elevation in an asymptomatic-or-skull-symptom patient is the Paget's signature, and zoledronic acid is the answer. The trap the exam loves is to give you a normal calcium in both cases and dare you to forget that osteoporosis labs are clean while Paget's labs are clean except alk phos. If alk phos is up AND calcium and phosphate are down with high PTH, you've left bone density disorders entirely and entered osteomalacia.
Worked examples
Which of the following is the most appropriate next step in management?
- A Initiate oral alendronate, with calcium and vitamin D supplementation ✓ Correct
- B Begin teriparatide as first-line therapy
- C Recommend calcium and vitamin D supplementation alone and repeat DEXA in 2 years
- D Order serum protein electrophoresis before initiating any pharmacotherapy
Why A is correct: This patient has postmenopausal osteoporosis confirmed both densitometrically (T-scores ≤ -2.5) and clinically (fragility fracture from a fall at standing height). With normal calcium, phosphate, alk phos, PTH, and TSH, secondary causes are unlikely, and the standard first-line therapy is an oral bisphosphonate such as alendronate, given alongside calcium and vitamin D to ensure substrate is available for any new bone formation.
Why each wrong choice fails:
- B: Teriparatide is a recombinant PTH analog reserved for patients with very severe osteoporosis (T-score < -3.5), multiple vertebral fractures, or failure of bisphosphonate therapy — it is not first-line for a typical postmenopausal patient with a single fragility fracture and T-scores around -2.6 to -2.9.
- C: Calcium and vitamin D alone are inadequate once a fragility fracture has occurred or DEXA confirms osteoporosis; supplementation is necessary substrate but does not slow bone loss meaningfully — failing to add a bisphosphonate leaves the patient at high risk for recurrent fracture. (The Clean-Labs Fragility Fracture)
- D: SPEP would be reasonable if there were features of multiple myeloma (anemia, hypercalcemia, renal failure, bone pain in unusual locations), but this patient has a typical postmenopausal phenotype, normal calcium, normal creatinine, and a classic fragility-fracture mechanism — routine SPEP screening is not indicated and would only delay needed therapy.
Which of the following is the most appropriate next step in management?
- A Refer for liver biopsy to evaluate elevated alkaline phosphatase
- B Initiate intravenous zoledronic acid ✓ Correct
- C Begin oral calcium and high-dose ergocalciferol
- D Schedule open biopsy of the tibial lesion to rule out osteosarcoma
Why B is correct: This is classic Paget's disease of bone: an older patient with skull enlargement, focal bone pain, hearing loss, isolated alkaline phosphatase elevation (with normal GGT and transaminases confirming bone origin), and pathognomonic radiographic findings. The standard treatment is a potent bisphosphonate, and IV zoledronic acid is preferred for its convenience and durable suppression of bone turnover.
Why each wrong choice fails:
- A: Although alk phos is dramatically elevated, the normal GGT and normal transaminases indicate bone-derived rather than hepatic alk phos — combined with the classic clinical and radiographic findings, the source is unambiguously skeletal and a liver biopsy would be wasted invasiveness. (The Isolated Alk Phos Pattern)
- C: Calcium and vitamin D address osteomalacia, where you would expect low calcium, low phosphate, and elevated PTH — this patient's calcium and phosphate are normal and there is no evidence of vitamin D deficiency, so supplementation alone neither treats Paget's nor addresses the patient's symptoms. (The Osteomalacia Distractor)
- D: Osteosarcoma is a rare late complication of long-standing Paget's, but it is suggested by sudden worsening pain, a soft-tissue mass, or rapid lytic destruction — the radiographic picture here (cortical thickening with a flame-shaped lytic front) is the typical mixed-phase Paget's appearance and does not warrant an upfront cancer workup before treating the underlying disease.
Which of the following best explains this patient's vertebral compression fracture?
- A Glucocorticoid-induced osteoporosis with reduced osteoblast function and increased osteoclast survival ✓ Correct
- B Paget's disease of bone with disordered remodeling weakening the vertebral body
- C Vitamin D deficiency causing defective mineralization of vertebral osteoid
- D Multiple myeloma with focal lytic destruction of the vertebral body
Why A is correct: Chronic glucocorticoid exposure (≥ 5 mg prednisone daily for ≥ 3 months) is a leading cause of secondary osteoporosis. Glucocorticoids suppress osteoblast differentiation and lifespan while prolonging osteoclast survival, producing rapid bone loss most pronounced in trabecular sites like the vertebral body — exactly where this patient fractured. Even though his T-scores are not below -2.5, glucocorticoid users fracture at higher T-scores than postmenopausal patients, and the clinical context plus the fragility-pattern fracture confirms the mechanism.
Why each wrong choice fails:
- B: Paget's disease produces isolated alk phos elevation and characteristic imaging changes (cortical thickening, lytic-sclerotic lesions), neither of which is present here — alk phos is normal at 95 and the vertebral imaging shows a simple wedge compression, not Pagetic remodeling.
- C: Osteomalacia from vitamin D deficiency would show low or low-normal calcium and phosphate, elevated alk phos, and elevated PTH — this patient's 25-OH vitamin D is 32 ng/mL with completely normal calcium, phosphate, alk phos, and PTH, ruling out a mineralization defect. (The Osteomalacia Distractor)
- D: Multiple myeloma typically presents with anemia, hypercalcemia, renal dysfunction, and lytic lesions on imaging — this patient has normal calcium, normal CBC, normal creatinine, and a wedge compression rather than a punched-out lytic lesion, making myeloma very unlikely without further screening features.
Memory aid
"Quiet labs, loud DEXA = osteoporosis. Loud alk phos, quiet calcium = Paget's. Loud everything (low Ca, low Phos, high alk phos, high PTH) = osteomalacia." For Paget's complications: "HEARS-FRACTURES-FAILS-CANCER" — Hearing loss, Fractures, High-output Failure, Sarcoma.
Key distinction
Osteoporosis has normal labs across the board and is diagnosed on DEXA; Paget's has isolated alkaline phosphatase elevation with normal calcium and phosphate and is diagnosed on imaging plus alk phos. Both are treated with bisphosphonates, but the diagnostic test that confirms each is different — order DEXA for the first, plain films plus alk phos (and bone scan to map extent) for the second.
Summary
For metabolic bone disorders, anchor on the lab pattern first: clean labs with low DEXA = osteoporosis; isolated high alk phos with normal calcium = Paget's; low calcium + low phosphate + high alk phos + high PTH = osteomalacia.
Practice bone disorders (osteoporosis, paget's) adaptively
Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is bone disorders (osteoporosis, paget's) on the USMLE Step 1 & 2?
Osteoporosis is a quantitative defect — normal bone mineralization but reduced bone mass — diagnosed by DEXA T-score ≤ -2.5 with normal calcium, phosphate, and alkaline phosphatase. Paget's disease is a focal disorder of disordered, accelerated bone remodeling producing thickened but mechanically weak bone, classically with isolated alkaline phosphatase elevation and normal calcium/phosphate. Both feature normal serum calcium, but Paget's gives you a dramatically elevated alk phos and characteristic imaging (cortical thickening, lytic-then-sclerotic phases), while osteoporosis labs are essentially clean and the diagnosis is densitometric.
How do I practice bone disorders (osteoporosis, paget's) questions?
The fastest way to improve on bone disorders (osteoporosis, paget's) is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for bone disorders (osteoporosis, paget's)?
Osteoporosis has normal labs across the board and is diagnosed on DEXA; Paget's has isolated alkaline phosphatase elevation with normal calcium and phosphate and is diagnosed on imaging plus alk phos. Both are treated with bisphosphonates, but the diagnostic test that confirms each is different — order DEXA for the first, plain films plus alk phos (and bone scan to map extent) for the second.
Is there a memory aid for bone disorders (osteoporosis, paget's) questions?
"Quiet labs, loud DEXA = osteoporosis. Loud alk phos, quiet calcium = Paget's. Loud everything (low Ca, low Phos, high alk phos, high PTH) = osteomalacia." For Paget's complications: "HEARS-FRACTURES-FAILS-CANCER" — Hearing loss, Fractures, High-output Failure, Sarcoma.
What's a common trap on bone disorders (osteoporosis, paget's) questions?
Forgetting that osteoporosis labs are normal — picking osteomalacia because alk phos is borderline
What's a common trap on bone disorders (osteoporosis, paget's) questions?
Calling isolated alk phos elevation a liver problem instead of Paget's
Ready to drill these patterns?
Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more bone disorders (osteoporosis, paget's) questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial